Indena is striving for APAC growth with market entry in Japan and China, and launching a more bioavailable formulation of coenzyme Q10 (CoQ10), which the firm believes has potential for success in sports nutrition and beyond.
The recent slew of crackdowns, regulatory reviews and stricter rules for China's health food and supplement industry are 'growing pains' the industry must overcome, as regulators double down on efforts to promote safety and collect taxes.
Chr. Hansen applies its microbiome expertise in the pharma arena as the firm enters a collaboration with Lonza to produce live biotherapeutic (LBP) products that address a range of gastrointestinal and cardiovascular conditions.
Pure plant matter should be prioritised over botanical extracts if herbal supplement makers hope to achieve longevity in the industry, according to one industry player which is seeing its wholly plant-based supplements business soar
New studies using palmitoylethanolamide, an endocannabinoid-like molecule with potent anti-inflammatory properties, may offer formulators possibilities for new joint health and sports recovery products, and an alternative to CBD.